DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX

Cell Death and Disease

Volumn 6, Issue 1, 2015, Pages

  Guan, J J ^a   Zhang, X D ^a   Sun, W ^a   Qi, L ^a   Wu, J C ^a   Qin, Z H ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; CASPASE 3; CATHEPSIN B; CYTOCHROME C; DNA DAMAGE REGULATED AUTOPHAGY MODULATOR 1; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; PROTEIN; PROTEIN BAX; PROTEIN BID; UNCLASSIFIED DRUG; DRAM1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN BINDING;

ACIDIFICATION; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL LEVEL; CELL MEMBRANE PERMEABILITY; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; DRAM1 GENE; ENZYME ACTIVATION; FEMALE; GENE; HALF LIFE TIME; HELA CELL LINE; HUMAN; HUMAN CELL; LYSOSOME; LYSOSOME MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING; BIOLOGICAL MODEL; GENETIC TRANSCRIPTION; METABOLISM; PROTEIN TRANSPORT; TUMOR CELL LINE;

APOPTOSIS; AUTOPHAGY; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CATHEPSIN B; CELL LINE, TUMOR; CYTOCHROMES C; HUMANS; LYSOSOMES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEOLYSIS; TRANSCRIPTION, GENETIC;

EID: 84927661476     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.546     Document Type: Article

References (45)

1. Nezis IP, Shravage BV, Sagona AP, Johansen T, Baehrecke EH, Stenmark H. Autophagy as a trigger for cell death: autophagic degradation of inhibitor of apoptosis dBruce controls DNA fragmentation during late oogenesis in Drosophila. Autophagy 2010; 6: 1214-1215.
2. McPhee CK, Logan MA, Freeman MR, Baehrecke EH. Activation of autophagy during cell death requires the engulfment receptor Draper. Nature 2010; 465: 1093-1096.
3. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-939.
4. Crighton D, Wilkinson S, Ryan KM. DRAM links autophagy to p53 and programmed cell death. Autophagy 2007; 3: 72-74.
5. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126: 121-134.
6. Takahashi M, Kakudo Y, Takahashi S, Sakamoto Y, Kato S, Ishioka C. Overexpression of DRAM enhances p53-dependent apoptosis. Cancer Med 2013; 2: 1-10.
7. Zhang XD, Wang Y, Zhang X, Han R, Wu JC, Liang ZQ et al. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 2009; 5: 339-350.
8. Zhang XD, Qi L,Wu JC, Qin ZH. DRAM1 regulates autophagy flux through lysosomes. PLoS One 2013; 8: e63245.
9. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139: 1281-1292.
10. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 387: 773-776.
11. Wei Q, Dong G, Franklin J, Dong Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 2007; 72: 53-62.
12. Reed JC. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 2006; 13: 1378-1386.
13. Li B, Dou QP. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci USA 2000; 97: 3850-3855.
14. Fu NY, Sukumaran SK, Kerk SY, Yu VC. Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism. Mol Cell 2009; 33: 15-29.
15. Nunes CT, Miners KL, Dolton G, Pepper C, Fegan C, Mason MD, et al. A novel tumor antigen derived from enhanced degradation of bax protein in human cancers. Cancer Res 2011; 71: 5435-5444.
16. Zhang H, Zhong C, Shi L, Guo Y, Fan Z. Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to necroptosis. J Immunol 2009; 182: 6993-7000.
17. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-490.
18. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
19. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144: 891-901.
20. Kagedal K, Johansson AC, Johansson U, Heimlich G, Roberg K, Wang NS et al. Lysosomal membrane permeabilization during apoptosis - involvement of Bax? Int J Exp Pathol 2005; 86: 309-321.
21. Feldstein AE, Werneburg NW, Li Z, Bronk SF, Gores GJ. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1339-G1346.
22. Breitschopf K, Haendeler J, Malchow P, Zeiher AM, Dimmeler S. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol 2000; 20: 1886-1896.
23. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet 1996; 30: 405-439.
24. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T et al. The role of autophagy during the early neonatal starvation period. Nature 2004; 432: 1032-1036.
25. Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001; 152: 657-668.
26. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132-141.
27. Chan EY. mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex. Sci Signal 2009; 2: pe51.
28. Iveson GP, Bird SJ, Lloyd JB. Passive diffusion of non-electrolytes across the lysosome membrane. Biochem J 1989; 261: 451-456.
29. Karpinich NO, Tafani M, Schneider T, Russo MA, Farber JL. The course of etoposideinduced apoptosis in Jurkat cells lacking p53 and Bax. J Cell Physiol 2006; 208: 55-63.
30. Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2000; 2: 754-761.
31. Sai T, Matsuda F, Goto Y, Maeda A, Sugimoto M, Gao HM et al. Effect of RNA interference of BID and BAX mRNAs on apoptosis in granulosa cell-derived KGN cells. J Reprod Dev 2012; 58: 112-116.
32. Yin X, Cao L, Kang R, Yang M, Wang Z, Peng Y et al. UV irradiation resistance-associated gene suppresses apoptosis by interfering with BAX activation. EMBO Rep 2011; 12: 727-734.
33. Rubinstein AD, Eisenstein M, Ber Y, Bialik S, Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 2011; 44: 698-709.
34. Crighton D, O'Prey J, Bell HS, Ryan KM. P73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ 2007; 14: 1071-1079.
35. Johnson BN, Berger AK, Cortese GP, Lavoie MJ. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc Natl Acad Sci USA 2012; 109: 6283-6288.
36. Yu M, Liu FT, Newland AC, Jia L. The alpha-5 helix of Bax is sensitive to ubiquitin-dependent degradation. Biochem Biophys Res Commun 2008; 371: 10-15.
37. Liu FT, Agrawal SG, Gribben JG, Ye H, Du MQ, Newland AC et al. Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood 2008; 111: 2797-2805.
38. Benard G, Neutzner A, Peng G, Wang C, Livak F, Youle RJ et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation. EMBO J 2010; 29: 1458-1471.
39. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102: 8204-8209.
40. Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 2005; 6: 439-448.
41. Oberle C, Huai J, Reinheckel T, Tacke M, Rassner M, Ekert PG et al. Lysosomal membrane permeabilization and cathepsin release is a Bax/Bak-dependent, amplifying event of apoptosis in fibroblasts and monocytes. Cell Death Differ 2010; 17: 1167-1178.
42. Bai M, Campisi L, Freimuth P. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2. J Virol 1994; 68: 5925-5932.
43. Iwaki T, Umemura K. A single plasmid transfection that offers a significant advantage associated with puromycin selection, fluorescence-assisted cell sorting, and doxycyclineinducible protein expression in mammalian cells. Cytotechnology 2011; 63: 337-343.
44. Sun L, Trausch-Azar JS, Ciechanover A, Schwartz AL. Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation. J Biol Chem 2005; 280: 26448-26456.
45. Lu Z, Tian Y, Salwen HR, Chlenski A, Godley LA, Raj JU et al. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Anticancer Drugs 2013; 24: 484-493.